Diagnostic utility of cerebrospinal fluid biomarkers in patients with rapidly progressive dementia.
Lindsey A KuchenbeckerPhilip Wade TiptonYuka MartensMatthew R BrierNihal SatyadevS Richard DunhamEvelyn B LazarMaxwell V DacquelRachel L HensonGuojun BuMichael D GeschwindJohn C MorrisSuzanne E SchindlerElizabeth HerriesNeill R Graff-RadfordGregory S DayPublished in: Annals of neurology (2023)
Selected CSF biomarkers at presentation associated with etiologic diagnoses and treatment responsiveness in patients with heterogeneous causes of RPD. The ability of cross-sectional biomarkers to inform upon mechanisms that drive rapidly progressive neurodegenerative disease is less clear. This article is protected by copyright. All rights reserved.